Related Announcements

NOT-MD-22-006 - Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities

NOT-AR-21-009 - NIAMS Policy for Acceptance of Clinical Trial Applications and Participation in Parent R01 and R21(Clinical Trial Required) Announcements

PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

This notice is to inform applicants that National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is participating, effective immediately, in NOT-MD-22-006, "Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities." NIAMS is interested in applications that concern the uptake of vaccination, especially for SARS-CoV-2, among populations that experience health disparities and are patients with NIAMS core mission diseases (arthritis, musculoskeletal, and skin disorders).

Please note that NIAMS will support non-mechanistic clinical trials designed to improve vaccine uptake under NOT-MD-22-006 via Funding Opportunity Announcement (FOA) PA-20-183. This is a single exception to our previously announced guidance in NOT-AR-21-009.

Inquiries

Please direct all inquiries to:

Stephanie M. George, PhD, MPH, MA
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phone: 301-594-4974
E-mail: [email protected]